drugset / Trial / NCT02494609
Oral Contraceptive DDI Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A Two-way Study to Evaluate the Potential Pharmacokinetic Interactions Between Sotagliflozin (LX4211) and an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol, in Healthy Premenopausal Women.
Timeline
- Start
- 2015-07
- Primary completion
- 2015-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norgestimate | Small molecule | 0.25 mg | Oral |
| Subject | Sotagliflozin | Small molecule | 400 mg | — |
| Subject | ethinyl estradiol | Small molecule | 0.035 mg | Oral |
Indications
No indication recorded.